fda warning bpc 157 human use not approved Understanding the Legal Risks of BPC-157 and Other Unapproved Peptides – Holt Law What Is BPC-157: Benefits, Uses
Description
Frontier Peptide Labs supplies 5-Amino-1MQ strictly for research and development use only
Avoid contact during pregnancy and breastfeeding
Robust Phase 2/3 studies are still lacking and most of the evidence remains preclinical
Most users report noticeable improvements within 7 to 14 days, with optimal results typically achieved over a 4 to 8 week protocol
Additionally, vitamin B12 deficiency can cause paresthesia or numbness in the limbs
Bon-Frauches AC, Boesmans W (2020) The enteric nervous system: the hub in a star network
